期刊文献+

黄芪注射液对充血性心力衰竭左心室重构影响的临床研究 被引量:44

下载PDF
导出
摘要 目的 观察黄芪注射液对充血性心力衰竭患者血流动力学效应、心功能和左心室重构影响,探讨中药治疗心力衰竭的机制。方挂采用随机单盲法将83例患者分为对照组43人,按临床常规治疗,治疗组40人,加用黄芪注射液40ml入5~10%葡萄糖溶液250ml静滴,每日1次,连续30天。采用超声心动图单盲法测定心功能,测量IVSD、LVIDD、LVPWD、LVEF、SV,并计算BAS、LVMI。结果 治疗后两组心功能较前改善,且治疗组心功能各项指标改善(P〈0.05)优于对照组。结论 伍用黄芪注射液可明显地改善衰竭心脏的心功能,其机制可能与改善心肌细胞能量代谢有关。
作者 焦雄文 段颖
出处 《陕西中医学院学报》 2006年第3期19-20,共2页 Journal of Shaanxi College of Traditional Chinese Medicine
  • 相关文献

参考文献4

  • 1Hammond ZW,Deveroux RB,Alderman MH,et al.Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive empoyed adults[J].JACC,1988,(12):1004.
  • 2Palatini P,Visentin P,Mormino P,et al.Structural abnormalities and not diastolic dysfunction are the earliest left ventricular changes in hrpertension[J].Am J Hypertens,1998,11:147-156.
  • 3曹济民.心力衰竭实验研究进展[J].基础医学与临床,2002,22(1):16-25. 被引量:35
  • 4赵智深 刘富喜 杨留振.黄芪注射液辅助治疗充血型心力衰竭[J].中国中西医结合杂志,1998,(11):26-26.

二级参考文献49

  • 1Francis GS. Pathophysiology of chronic heart failure[J]. Am J Med, 2001,110(Suppl 7A): 37S-46S.
  • 2Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress[J]. Circulation, 2000,102:IV-14.
  • 3Sabbah HN. Apoptotic cell death in heart failure[J]. Cardiovasc Res, 2000, 45:704-712.
  • 4Ungerer M, Bohm M, Elce JS, et al. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart[J]. Circulation,1993,87:454-463.
  • 5Lup WI, Grupp IL, Harrer J, et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation[J]. Circ Res,1994,75:401-409.
  • 6Wagoner LE, Craft LL, Singh B, et al. Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure[J]. Circ Res, 2000,86: 834-840.
  • 7Packer M, Bristow MR, Cohn JN, et al. Effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J]. N Engl J Med,1996,334:1349-1355.
  • 8MacLellan WR. Advances in the molecular mechanisms of heart failure[J]. Current Opin Cardiol, 2000, 15:128-135.
  • 9Zannad F, Dousset B, Alla F. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship[J]. Hypertension, 2001,38: 1227-1232.
  • 10Yoshimura M, Yasue H, Ogawa H. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure[J]. Can J Physiol Pharmacol, 2001,79:730-735.

共引文献35

同被引文献468

引证文献44

二级引证文献284

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部